Tuesday, 10 July 2018

Takeda gets key U.S. regulatory approval to buy Shire

Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc.


from Reuters: Top News https://ift.tt/2NBPP2B
//

0 comments:

Post a Comment